Zepp Health Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023)

Like
Comment
Favorite

Zepp Health Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023)

Simply Wall St.08-23

Zepp Health (NYSE:ZEPP) Second Quarter 2024 Results Key Financial Results Revenue: US$40.6m (down 55% from 2Q 2023). Net loss: US$10.8m (loss widened by 12% from 2Q 2023). US$0.17 loss per share (...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2461256152?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","is_english":true,"pubTime":"2024-08-23 18:36","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2461256152","market":"us","top_or_hot":-1,"title":"Zepp Health Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023)","media":"Simply Wall St.","content":"<div>\n<p>Zepp Health (NYSE:ZEPP) Second Quarter 2024 Results\nKey Financial Results\n\nRevenue: US$40.6m (down 55% from 2Q 2023).\nNet loss: US$10.8m (loss widened by 12% from 2Q 2023).\nUS$0.17 loss per share (...</p>\n\n<a href=\"https://finance.yahoo.com/news/zepp-health-second-quarter-2024-103623341.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zepp Health Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZepp Health Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-23 18:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/zepp-health-second-quarter-2024-103623341.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zepp Health (NYSE:ZEPP) Second Quarter 2024 Results\nKey Financial Results\n\nRevenue: US$40.6m (down 55% from 2Q 2023).\nNet loss: US$10.8m (loss widened by 12% from 2Q 2023).\nUS$0.17 loss per share (...</p>\n\n<a href=\"https://finance.yahoo.com/news/zepp-health-second-quarter-2024-103623341.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZEPP","symbol_name":"华米科技","start_time":0,"source_url":"https://finance.yahoo.com/news/zepp-health-second-quarter-2024-103623341.html","article_id":"2461256152","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2461256152","pubTimestamp":1724409383,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"NYSE:ZEPP Earnings and Revenue Growth August 23rd 2024. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 7.6% growth forecast for the Electronic industry in the US.The company's shares are down 1.3% from a week ago.You should always think about risks. Case in point, we've spotted   2 warning signs for Zepp Health  you should be aware of.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ZEPP":"华米科技"},"translate_title":"Zepp Health 2024年第二季度收益：美国每股亏损0.17美元（美国2023年第二季度亏损0.16美元）","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZEPP":0.9},"content_text":"Zepp Health (NYSE:ZEPP) Second Quarter 2024 Results\nKey Financial Results\n\nRevenue: US$40.6m (down 55% from 2Q 2023).\nNet loss: US$10.8m (loss widened by 12% from 2Q 2023).\nUS$0.17 loss per share (further deteriorated from US$0.16 loss in 2Q 2023).\n\n\n\n\n  NYSE:ZEPP Earnings and Revenue Growth August 23rd 2024\n \n\nAll figures shown in the chart above are for the trailing 12 month (TTM) period\nZepp Health Earnings Insights\n Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 7.6% growth forecast for the Electronic industry in the US. \nPerformance of the American Electronic industry.\n The company's shares are down 1.3% from a week ago. \nRisk Analysis\n You should always think about risks. Case in point, we've spotted   2 warning signs for Zepp Health  you should be aware of. \nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}